1Core Working Party For Asia-Pacific Consensus On Hepatitis B And C.Consensus statements on the prevention and management of hepatitis B and hepatitis C in the Asia-Pacific region[].Journal of Gastroenterology.2000
2Niederau C,Heintges T,Lange S,et al.Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B[].The New England Journal of Medicine.1996
3Heathcote EJ,Jeffers L,Wright T,et al.Loss of serum HBV DNA and HBeAg and seroconversion following short-term ( 12 weeks) adefovir dipivoxil therapy in chronic hepatitis B: two placebo-controlled phase Ⅱ studies ( abstr )[].Hepatology.1998
4Pastore G,Santantonio T,Milella A,et al.Anti-HBe-positive chronic hepatitis B with HBV-DNA in the serum: respones to a 6month course of lymphoblastoid interferon[].Journal of Hepatology.1992
5Perrillo RP,Wright T,Rakela J,et al.A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B[].Hepatology.2001
6Chien RN,Liao YF,Chen TC,et al.Efficacy of thymosinα1 in patients with chronic type B hepatitis: a randomized controlled trial[].Hepatology.1998
7Chang TT,Lai CL,Liaw YF,et al.Incremental increases in HBeAg seroconversion and continued ALT normalization in Asian chronic HBV patients treated with lamivudine for four years(abstr)[].Antiviral Therapy.2000
8Hadziyannis S,Bramou T,Makris A,et al.Interferon alfa-2b treatment lf HBeAg negative serum HBV DNA positive chronic active hepatitis B[].Journal of Hepatology.1990
9Greenberg HB,Pollard RB,Lutwick LI,et al.Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis[].The New England Journal of Medicine.1976
10Tassopoulos NC,Volpes R,Pastore G,et al.Efficacy of lamivudine in patients with hepatitis B e antigen-negative hepatitis B virus DNA-positive ( precore mutant) chronic hepatitis B[].Hepatology.1999
